Schizophrenia trials in South Korea
4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Where
- Ansan-si, Gangwon-do, Seoul, Yeongdeungpo-gu, Yongin-si
- Age
- 55 years to 90 years
- People
- 406 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Where
- Daegu, Incheon
- Age
- 55 years to 90 years
- People
- 300 worldwide
- Run by
- MapLight Therapeutics
See details and how to joinNCT06887192 · EU 2024-519820-26-00 - No phaseTaking peopleDigital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Disorder
- Where
- Seoul
- Age
- 19 years to 60 years
- People
- 60
- Run by
- Samsung Medical Center
See details and how to joinNCT07755605 - Phase 2Taking peopleA Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia
- Where
- Daegu, Guri-si
- Age
- 19 years and over
- People
- 120
- Run by
- Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT06821945